Trials / Completed
CompletedNCT04585139
Assessing Non-adjunctive CGM Safety at Home and in New Markets
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- DexCom, Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to examine whether non-adjunctive (without having to double check using another method) use of Continuous Glucose Monitoring improves A1c in adults or children with diabetes managed by intensive insulin therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Phase 1- Introduction to Dexcom G6 CGM | Examine whether non-adjunctive use of CGM improves glycemic control in adults with diabetes managed by intensive insulin therapy |
Timeline
- Start date
- 2020-10-06
- Primary completion
- 2022-02-07
- Completion
- 2022-02-07
- First posted
- 2020-10-14
- Last updated
- 2022-08-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04585139. Inclusion in this directory is not an endorsement.